The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
about
Erythropoietin enhances hippocampal long-term potentiation and memoryErythropoietin: powerful protection of ischemic and post-ischemic brainDevelopmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: do data justify changing clinical practice?Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats.Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trialHemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis.Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trialGrowth factors in ischemic stroke.Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathwayRole of erythropoietin in the brainRecombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.Anemia and risk of dementia in older adults: findings from the Health ABC study.Anemia of inflammation in critically ill patients.Brain-regulated metabolic suppression during hibernation: a neuroprotective mechanism for perinatal hypoxia-ischemia.Relation of hemoglobin to level of cognitive function in older persons.Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.Erythropoietin promotes neurological recovery after intracerebral haemorrhage in rats.Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activityTRPC3 activation by erythropoietin is modulated by TRPC6.Anemia and Mild Cognitive Impairment in the German General Population.Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial.Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy.Erythrocytes as Potential Link between Diabetes and Alzheimer's DiseaseErythropoietin attenuates advanced glycation endproducts-induced toxicity of Schwann cells in vitro.EV-3, an endogenous human erythropoietin isoform with distinct functional relevance.Modulation of neurogenesis by targeted hippocampal irradiation fails to affect kindling progression.Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.Erythropoietin: recent developments in the treatment of spinal cord injuryInvestigation of the protective effect of erythropoietin on spinal cord injury in rats.Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings.Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis.Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors.Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).Effects of erythropoietin on blood-brain barrier tight junctions in ischemia-reperfusion rats.
P2860
Q21245342-5BB36872-2364-4B7E-BDF0-566D329A51FCQ26999392-BF61A52B-79C1-4D64-915E-E052A90AFE4CQ34124787-2684E39D-DB5F-427B-840C-89BF25300795Q34558891-2E19890C-717C-442D-969D-1030A616FA02Q34663582-CF330E22-E787-4F22-9EA2-3FEAD58907B5Q35104459-029D3570-EA94-4E2A-87F5-FBA45630D9CAQ35147461-1F5DCF8D-265B-40DE-99D6-405476305166Q35216143-616A0AF8-C0D8-406B-A4D0-AC2C76B2592FQ35440761-CE86A24E-A93A-409A-8761-F80FF154B5F1Q35566925-10571E0E-A348-4520-A4D9-C0D48B3A345CQ35858747-83082509-70D6-46DC-8D9E-F8F2293F5065Q36153802-4BE9A0A0-BA2D-4448-9ECE-5EB406EFBB62Q36481623-E751903D-8E61-4BA2-A606-BAD6D13D4068Q37178754-2BF55A12-5726-4B63-9E00-2148B842E394Q37243130-B379F99B-66FD-4B7D-BD61-E05525EA04F2Q37244550-BEBFD228-0025-4685-93DF-35995939D9CAQ37337424-01BA8A6F-31D2-4F0D-B0F7-5D56036A52A1Q37358669-6AFA47ED-5EE6-4A1E-8D1D-734B8B9EBFCCQ37379130-85B4E932-416A-4E67-8CE9-D4944B66EB31Q38629057-FDFB068A-09A4-4C9B-89B3-CE0F91CD2A8EQ39660329-ACB61887-295D-4AE8-9824-6EFF17A39C46Q39906185-1088DE5F-DE76-45E9-B84F-D8EBE743F69FQ41102763-84B757AC-EB8D-4D1A-B941-2FD1F86A2AC0Q41469526-EA886698-83E4-4530-9F74-1FE9381EFE2DQ41529847-FB2B40B0-BF67-40EE-AB67-9E7EC7A7D1E1Q41547214-057DFAE0-ED2F-49D9-8D0B-3EA1BF4B826DQ41587516-66E47CCF-4EEF-4902-B336-5808571B788BQ42003728-94C6F24D-D4BA-4D43-9801-D47D3A5C5621Q42477495-93A6405F-AF67-4C50-90F9-3FEC089865F0Q42729265-EFE5A83F-1379-4B14-91E2-F039368B4C95Q42797884-E915F1B6-2F3E-408B-8279-5CDB25332072Q43080140-438E26C6-2D05-4E1A-B90E-39AFFCC8DF2FQ43863411-0871FADD-C742-4381-9C74-1081731747B9Q45076147-AFBE2498-68DF-4E6E-83A6-99573E08200AQ46082665-C8044906-4791-4A43-93BE-DF308964134BQ46258459-8D288FA7-E561-4283-885C-E9A4C3688BF7Q47138809-B7DA08AD-3D87-4ADB-85C2-CDB5CC604488Q47420387-2B28F6FB-5E50-4269-9065-CA9F60C9EF19Q48189448-2056B6B6-99A3-4B61-9064-4ACC53641614Q48365906-359C7B8A-9BE8-444E-A28A-679FDCCA07FD
P2860
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The brain erythropoietin syste ...... exploitation in brain disease.
@ast
The brain erythropoietin syste ...... exploitation in brain disease.
@en
type
label
The brain erythropoietin syste ...... exploitation in brain disease.
@ast
The brain erythropoietin syste ...... exploitation in brain disease.
@en
prefLabel
The brain erythropoietin syste ...... exploitation in brain disease.
@ast
The brain erythropoietin syste ...... exploitation in brain disease.
@en
P50
P1476
The brain erythropoietin syste ...... exploitation in brain disease.
@en
P304
P356
10.1097/00008506-200604000-00007
P577
2006-04-01T00:00:00Z